A new generation of autonomous laboratories could transform how medicines are discovered. Startup Medra is developing robotic labs where machines run experiments continuously, collecting vast amounts of data that scientists often overlook. Robotic arms track precise details such as pipette angles, dipping depth, mixing speeds, and timing between chemical additions while recording every failed attempt. This data may be the key to the next wave of artificial intelligence in drug discovery.
According to Medra CEO, scientific frontier models may need up to 1,000 times more experimental data. To accelerate this process, Medra recently raised $52 million and partnered with Greentech to build facilities where hundreds of robots can run experiments around the clock.
By learning from every success and failure, these AI-driven systems could dramatically speed up drug discovery, potentially uncovering future cancer treatments from millions of experiments that humans might never have performed.
If AI can learn from millions of failed experiments, could the next breakthrough drug be discovered not by humans but by machines?
MBH/PS